AFC Agro Biotech Limited

AFCAGRO

BD0489AFCAB3

Pharmaceuticals

End-of-day quote Dhaka S.E. Other stock markets 03:30:00 06/06/2024 am IST			5-day change	1st Jan Change
14.5 ^BDT	0.00%		+5.07%	-38.30%

2023	AFCAGRO Biotech Limited Enters into an Agreement with Bioneer Corporation to Produce Molecular Diagnostic Kits	CI
2023	AFC Agro Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	CI

AFC Agro Biotech Limited Announces Earnings Results for the Year Ended on June 30, 2018

October 28, 2018 at 04:35 pm IST

AFC Agro Biotech Limited announced earnings results for the year ended on June 30, 2018. For the year, the company reported EPS was BDT 3.47 (Normal Operation) and EPS of BDT 3.92 (Considering Tax reversal Impact), compared with BDT 3.32 (Normal Operation) and EPS of BDT 2.91 (Considering Tax reversal Impact), a year ago.

Latest news about AFC Agro Biotech Limited

AFCAGRO Biotech Limited Enters into an Agreement with Bioneer Corporation to Produce Molecular Diagnostic Kits	13/12	CI
AFC Agro Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	30/23/30	CI
AFC Agro Biotech Limited Reports Earnings Results for the First Quarter Ended September 30, 2022	18/22/18	CI
AFC Agro Biotech Limited Announce Approval for Supplying Corona Vaccine and Testing Kits	16/22/16	CI
AFC Agro Biotech Limited Elects Mr. S.M. Saifur Rahman as Chairman	08/22/08	CI
AFC Agro Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022	15/22/15	CI
AFC Agro Biotech Limited Reports Earnings Results for the Full Year Ended June 30, 2021	24/21/24	CI
AFC Agro Biotech Limited Reports Earnings Results for the First Quarter Ended September 30, 2021	30/21/30	CI
AFC Agro Biotech Limited Receives Approval for Supplying of RT- PCR Test Kit	29/21/29	CI
AFC Agro Biotech Limited Receives BSEC Consent for Issuing Non-Convertible Zero Coupon Bond	19/20/19	CI
AFC Agro Biotech Limited to Issue 5 Years Non-Convertible Zero Coupon Bond	02/19/02	CI
Afc Agro Biotech Limited Reports Earnings Results for the Third Quarter Ended March 31, 2019	15/19/15	CI
Afc Agro Biotech Limited Reports Earnings Results for the Second Quarter Ended December 31, 2018	28/19/28	CI
Afc Agro Biotech Limited Reports Earnings Results for the Full Year Ended June 30, 2018	08/18/08	CI
AFC Agro Biotech Limited Announces Earnings Results for the Year Ended on June 30, 2018	28/18/28	CI
AFC Agro Biotech Limited Reports Unaudited Earnings Results for the Third Quarter and Nine Months Ended March 31, 2018	30/18/30	CI
AFC Agro Biotech Limited Reports Unaudited Earnings Results for the Second Quarter and Six Months Ended December 2017	30/18/30	CI
AFC Agro Biotech Limited Announces Unaudited Earnings Results for the First Quarter Ended September 30, 2017	15/17/15	CI
AFC Agro Biotech Limited Announces Earnings Results for the Year Ended on June 30, 2017	29/17/29	CI
AFC Agro Biotech Limited Announces Unaudited Earnings Results for the Third Quarter and Nine Months Ended March 2017	30/17/30	CI
AFC Agro Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 2016	30/17/30	CI
AFC Agro Biotech Limited Announces Unaudited Earnings Results for the First Quarter Ended September 30, 2016	15/16/15	CI
14,238,750 Ordinary Shares of AFC Agro Biotech Ltd are subject to a Lock-Up Agreement Ending on 27-OCT-2016.	27/16/27	CI
AFC Agro Biotech Limited Reports Earnings Results for the Eighteen Months Period Ended June 30, 2016	19/16/19	CI
AFC Agro Biotech Begins Commercial Production of Industrial Enzymes	02/16/02	CI

Chart AFC Agro Biotech Limited

Duration

Period

More charts

Company Profile

AFC Agro Biotech Limited is a Bangladesh-based company, which is engaged in the manufacturing of biopharmaceuticals and biochemical. The Company also manufactures antibiotics, proteins, vaccines, enzymes from agricultural ingredients. The Company offers various products, including Erythromycin, L-Lysine, Acetic acid, Monosodium Glutamate (MSG) and l-lysine. The Company's Erythromycin product is a macrolide antibiotic that has an antimicrobial spectrum similar to or slightly wider than that of penicillin. The Company's L-lysine product is an amino acid. The Company's Acetic Acid product is an organic compound. The Company's Monosodium Glutamate product is a sodium salt of glutamic acid. The Company has set up a multi-purpose chemical manufacturing facility at Uttar Shoilmary, Koiya Bazar, Batiaghata, Khulna.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Biopharmaceuticals

	1st Jan change	Capi.
AFC AGRO BIOTECH LIMITED	-38.30%	1.42Cr
CSL LIMITED	+0.82%	9.32TCr
SAMSUNG BIOLOGICS CO.,LTD.	-1.32%	3.96TCr
BIOGEN INC.	-12.88%	3.38TCr
UCB	+64.77%	2.68TCr
BIOMARIN PHARMACEUTICAL INC.	-16.31%	1.54TCr
INCYTE CORPORATION	-5.78%	1.31TCr
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-11.38%	1.16TCr
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-49.84%	1.03TCr
SWEDISH ORPHAN BIOVITRUM AB	+5.24%	942.61Cr